Related Experiment Video

Updated: Jun 19, 2026

Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

A glimpse into the future: recombinant proteins and small molecules for targeted therapies in rheumatic diseases

J R Kalden1, J Braun

  • 1Abteilung für Molekulare Immunologie, Nikolaus-Fiebiger-Zentrum, Erlangen, Germany. jkalden@molmed.uni-erlangen.de

Clinical and Experimental Rheumatology
|October 14, 2009
PubMed

Insights

The clinical differences between rheumatoid arthritis (RA) and ankylosing spondylitis (AS) may require distinct treatments. New therapeutic strategies are necessary as current biologics are not universally effective.

Area of Science:

  • Rheumatology
  • Immunology
  • Pharmacology

Background:

  • Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are distinct inflammatory conditions.
  • Current biologic therapies, including anti-TNF-alpha agents, show variable efficacy in RA and AS patients.
  • The need for novel therapeutic approaches is evident due to treatment limitations.

Purpose of the Study:

  • To explore potential differences in therapeutic strategies for RA and AS.
  • To highlight the unmet need for new treatments in spondyloarthritis and RA.

Main Methods:

  • Comparative analysis of clinical and pathogenetic features of RA and AS.
  • Review of current treatment outcomes for biologic agents in RA and AS.

Main Results:

  • Clinical presentation and pathogenesis differ between RA and AS.
  • Existing biologics, such as anti-TNF-alpha agents, do not provide universal efficacy.
  • Significant patient populations do not respond adequately to current therapies.

Conclusions:

  • Distinct therapeutic strategies may be required for RA and AS based on their unique characteristics.
  • Further research and development of novel treatments are crucial for improving patient outcomes in these autoimmune diseases.

Related Concept Videos

Recombinant DNA01:09

Recombinant DNA

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: